CareLit · DOI-Nachweis · Klinische Pädiatrie
MicroRNA Signature Predicts Molecular Risk Groups in Medulloblastoma
DOI 10.1055/s-0029-1222673
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Remke, AHC Bai, A Pscherer, A Korshunov, P Northcott, M Taylor, P Lichter, A Kulozik, S Pfister
ZeitschriftKlinische Pädiatrie
Ausgabe05/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Medulloblastoma comprises the most common malignant pediatric brain tumor. Current treatment protocols are solely based on clinically defined risk-groups. Identification of novel tumor-derived markers may improve the risk assessment of medulloblastoma patients. Thus, array-CGH or FISH were carried out to determine tumor-specific genomic imbalances associated with overall survival (OS) in 340 medulloblastoma patients…
Zitieren
Zitierempfehlung
M Remke, AHC Bai, A Pscherer, A Korshunov, P Northcott, M Taylor, P Lichter, A Kulozik, S Pfister (2009) MicroRNA Signature Predicts Molecular Risk Groups in Medulloblastoma. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0029-1222673
Mit CareLit weiterarbeiten